News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quintiles, Inc. (QTRN), dabl Team to Advance Cardiovascular Safety Assessment



10/3/2012 10:12:40 AM

DUBLIN & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--dabl Limited, a provider of centralized ambulatory blood pressure measurement (ABPM) services, and Quintiles, the world’s leading global biopharmaceutical services company, today announced a strategic alliance that significantly enhances Quintiles’ suite of offerings in cardiovascular safety assessment. Through the alliance, Quintiles’ customers worldwide will have access to dabl’s round-the-clock ABPM services to enhance the safety and efficacy of global clinical trials across the entire trial lifecycle.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES